1. Home
  2. ALDX vs SFHG Comparison

ALDX vs SFHG Comparison

Compare ALDX & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • SFHG
  • Stock Information
  • Founded
  • ALDX 2004
  • SFHG 1993
  • Country
  • ALDX United States
  • SFHG Hong Kong
  • Employees
  • ALDX N/A
  • SFHG N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • SFHG Publishing
  • Sector
  • ALDX Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • ALDX 304.9M
  • SFHG 323.1M
  • IPO Year
  • ALDX 2014
  • SFHG 2024
  • Fundamental
  • Price
  • ALDX $5.40
  • SFHG $0.90
  • Analyst Decision
  • ALDX Strong Buy
  • SFHG
  • Analyst Count
  • ALDX 2
  • SFHG 0
  • Target Price
  • ALDX $10.00
  • SFHG N/A
  • AVG Volume (30 Days)
  • ALDX 394.0K
  • SFHG 1.0M
  • Earning Date
  • ALDX 03-06-2025
  • SFHG 12-20-2024
  • Dividend Yield
  • ALDX N/A
  • SFHG N/A
  • EPS Growth
  • ALDX N/A
  • SFHG N/A
  • EPS
  • ALDX N/A
  • SFHG 0.01
  • Revenue
  • ALDX N/A
  • SFHG $19,005,455.00
  • Revenue This Year
  • ALDX N/A
  • SFHG N/A
  • Revenue Next Year
  • ALDX N/A
  • SFHG N/A
  • P/E Ratio
  • ALDX N/A
  • SFHG $97.26
  • Revenue Growth
  • ALDX N/A
  • SFHG 31.66
  • 52 Week Low
  • ALDX $2.71
  • SFHG $0.61
  • 52 Week High
  • ALDX $6.55
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 60.04
  • SFHG N/A
  • Support Level
  • ALDX $4.95
  • SFHG N/A
  • Resistance Level
  • ALDX $5.10
  • SFHG N/A
  • Average True Range (ATR)
  • ALDX 0.24
  • SFHG 0.00
  • MACD
  • ALDX 0.04
  • SFHG 0.00
  • Stochastic Oscillator
  • ALDX 85.06
  • SFHG 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: